Home » Topics » BioWorld Science

BioWorld Science
RSS

WindMIL Therapeutics completes series B financing to support development of MILs

June 20, 2018

NINDS grant supports AcuraStem's work in ALS

June 20, 2018

EDELWEISS phase IIb study of linzagolix achieves primary and secondary endpoints

June 20, 2018

First-in-human results reported for MK-1248 in advanced solid tumors

June 19, 2018

Alexion submits U.S. BLA for ALXN-1210 to treat PNH

June 19, 2018

FDA places clinical hold on phase I trial evaluating Ziopharm's CD19-targeted CAR T therapy

June 19, 2018

Glycogen synthase kinase 3 inhibitors patented by Bristol-Myers Squibb

June 19, 2018

Shanghai Institute of Materia Medica discovers BTK inhibitors

June 19, 2018

Hedgehog pathway modulators patented by Development Center for Biotechnology, DCB-USA

June 19, 2018

Xavier University of Louisiana divulges androgen receptor signaling inhibitors

June 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...